These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32487562)

  • 1. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
    Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
    J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 3. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
    BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
    Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
    PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System.
    Goncalves GMR; Silva END
    PLoS One; 2018; 13(10):e0203992. PubMed ID: 30273345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially Preventable Hospitalization among Patients with CKD and High Inpatient Use.
    Ronksley PE; Hemmelgarn BR; Manns BJ; Wick J; James MT; Ravani P; Quinn RR; Scott-Douglas N; Lewanczuk R; Tonelli M
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2022-2031. PubMed ID: 27821636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and Outcomes of Health-Related Quality of Life in Adults with CKD.
    Porter AC; Lash JP; Xie D; Pan Q; DeLuca J; Kanthety R; Kusek JW; Lora CM; Nessel L; Ricardo AC; Wright Nunes J; Fischer MJ;
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1154-1162. PubMed ID: 27246012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of comorbid chronic kidney disease and diabetes.
    McQueen RB; Farahbakhshian S; Bell KF; Nair KV; Saseen JJ
    J Med Econ; 2017 Jun; 20(6):585-591. PubMed ID: 28128669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of progressive chronic kidney disease among patients with type 2 diabetes.
    Vupputuri S; Kimes TM; Calloway MO; Christian JB; Bruhn D; Martin AA; Nichols GA
    J Diabetes Complications; 2014; 28(1):10-6. PubMed ID: 24211091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus.
    Go AS; Yang J; Tan TC; Cabrera CS; Stefansson BV; Greasley PJ; Ordonez JD;
    BMC Nephrol; 2018 Jun; 19(1):146. PubMed ID: 29929484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Cardiovascular Disease and Chronic Kidney Disease on Life Expectancy and Direct Medical Cost in a 10-Year Diabetes Cohort Study.
    Wan EYF; Chin WY; Yu EYT; Wong ICK; Chan EWY; Li SX; Cheung NKL; Wang Y; Lam CLK
    Diabetes Care; 2020 Aug; 43(8):1750-1758. PubMed ID: 32457057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 15. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis.
    McEwan P; Hafner M; Jha V; Correa-Rotter R; Chernin G; De Nicola L; Villanueva R; Wheeler DC; Barone S; Nolan S; Garcia Sanchez JJ
    J Med Econ; 2023; 26(1):1407-1416. PubMed ID: 37807895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden and Cost of Caring for US Veterans With CKD: Initial Findings From the VA Renal Information System (VA-REINS).
    Saran R; Pearson A; Tilea A; Shahinian V; Bragg-Gresham J; Heung M; Hutton DW; Steffick D; Zheng K; Morgenstern H; Gillespie BW; Leichtman A; Young E; O'Hare AM; Fischer M; Hotchkiss J; Siew E; Hynes D; Fried L; Balkovetz D; Sovern K; Liu CF; Crowley S; ;
    Am J Kidney Dis; 2021 Mar; 77(3):397-405. PubMed ID: 32890592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-cause costs increase exponentially with increased chronic kidney disease stage.
    Golestaneh L; Alvarez PJ; Reaven NL; Funk SE; McGaughey KJ; Romero A; Brenner MS; Onuigbo M
    Am J Manag Care; 2017 Jun; 23(10 Suppl):S163-S172. PubMed ID: 28978205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes.
    Lage MJ; Boye KS; Bae JP; Wu J; Mody R; Botros FT
    J Med Econ; 2019 May; 22(5):447-454. PubMed ID: 30736708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure.
    Polson M; Lord TC; Kangethe A; Speicher L; Farnum C; Brenner M; Oestreicher N; Alvarez P
    J Manag Care Spec Pharm; 2017 Apr; 23(4-a Suppl):S2-S9. PubMed ID: 28436256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.